Callan Family Office, LLC Ligand Pharmaceuticals Inc Transaction History
Callan Family Office, LLC
- $1.57 Trillion
- Q4 2024
A detailed history of Callan Family Office, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Callan Family Office, LLC holds 2,438 shares of LGND stock, worth $274,933. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,438Holding current value
$274,933% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
267Shares Held
18MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$324 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$235 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$114 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$100 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$79.8 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.9B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...